Status:
UNKNOWN
Botulinum A Toxin in Patients With Parkinson's Disease
Lead Sponsor:
University Of Perugia
Collaborating Sponsors:
University of Roma La Sapienza
Conditions:
Parkinson's Disease
Multiple System Atrophy
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The researchers investigated the effectiveness and safety of BoNT/A injected into the detrusor muscle in patients with PD and MSA all of whom had detrusor muscle overactivity unresponsive to conventio...
Detailed Description
Patients included will have overactive bladder symptoms refractory to medical therapy. Other causes of overactive bladder symptoms including urogenital prolapse and recurrent urinary tract infections ...
Eligibility Criteria
Inclusion
- Patients with overactive bladder symptoms refractory to medical therapy.
Exclusion
- Other causes of overactive bladder symptoms including urogenital prolapse and recurrent urinary tract infections were excluded.
- Concomitant anticoagulant therapy or drugs interfering with neuromuscular transmission.
- Neuromuscular disease like Lambert-Eaton syndrome.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00822913
Start Date
June 1 2008
End Date
December 1 2009
Last Update
January 15 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.